In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo

Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0024. Online ahead of print.ABSTRACTJoosten LP, van Doorn S, van de Ven PM, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149:279-289. 37634130.PMID:38710082 | DOI:10.7326/J24-0024
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Source Type: research